Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.87)
# 3,593
Out of 4,829 analysts
209
Total ratings
16.55%
Success rate
-17.76%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.13 | +696.46% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.93 | +764.77% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.03 | +278.11% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.81 | +120.99% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.83 | +9.29% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $1.08 | +640.74% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.08 | +813.46% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.00 | +950.00% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.32 | +1,036.36% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.41 | +1,607.32% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.36 | +638.01% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.60 | +233.33% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +400.00% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.34 | +199.68% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $0.89 | +39,036.76% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.95 | +442.37% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.10 | +445.45% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.77 | +12,887.01% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.10 | +1,536.36% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.24 | +1,512.90% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.39 | +464,501.77% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.88 | +6,249.21% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $21.34 | +1,024.46% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.93 | +8,513.26% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.12 | +8,828.57% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.74 | +139,272.82% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.28 | +446.88% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.55 | +1,076.47% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.49 | +1,506.43% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.25 | +7,020.25% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.39 | +259.71% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $3.16 | +45,541.84% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $32.14 | -25.33% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.26 | +271,328.57% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.00 | +949,900.00% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.13
Upside: +696.46%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.93
Upside: +764.77%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.03
Upside: +278.11%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.81
Upside: +120.99%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.83
Upside: +9.29%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $1.08
Upside: +640.74%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.08
Upside: +813.46%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.00
Upside: +950.00%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.32
Upside: +1,036.36%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $7
Current: $0.41
Upside: +1,607.32%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.36
Upside: +638.01%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.60
Upside: +233.33%
Mar 4, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.34
Upside: +199.68%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $0.89
Upside: +39,036.76%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.95
Upside: +442.37%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.10
Upside: +445.45%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.77
Upside: +12,887.01%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.10
Upside: +1,536.36%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.24
Upside: +1,512.90%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.39
Upside: +464,501.77%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.88
Upside: +6,249.21%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $21.34
Upside: +1,024.46%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.93
Upside: +8,513.26%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.12
Upside: +8,828.57%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.74
Upside: +139,272.82%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.28
Upside: +446.88%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.55
Upside: +1,076.47%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.49
Upside: +1,506.43%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.25
Upside: +7,020.25%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $3.16
Upside: +45,541.84%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $32.14
Upside: -25.33%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.26
Upside: +271,328.57%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.00
Upside: +949,900.00%